About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $31.28 | Open | $31.42 |
| Volume | 7.56M | Market Cap | 11.109B |
| Yield | Last Dividend |
| Bausch Health and Landos Biopharma See A... | 02/26/21 |
| Icahn Capital reached a pact to appoint Bausch Health directors. Perceptive Advisors disclosed a large stake in Landos Biopharma. | |
| RBC Capital Stick to Their Buy Rating fo... | 02/25/21 |
| RBC Capital Stick to Their Buy Rating for Bausch Health Companies Inc | |
| Stocks to Buy Now: This One Is up Over 4... | 02/25/21 |
| Bausch Health stock is a solid buy today as it aims to create significant shareholder value - a concept that we at Motley Fool really like. The post S... | |
| Bausch Health reports full-year earnings... | 02/24/21 |
| Bausch Health Cos. Inc. on Wednesday reported fourth-quarter and full-year results, beating Street estimates. The company also said it plans to add tw... | |
| Bausch Health Adds 2 Directors Chosen By... | 02/24/21 |
| Bausch Health Companies Inc (NYSE: BHC ) is expanding its board of directors to accommodate two designees from activist investor Carl Icahn???s Icahn ... | |
| Should You Follow Carl Icahn Into Bausch... | 02/24/21 |
| Bausch Health Companies (TSX:BHC)(NYSE:BHC) is surging thanks to activist investor Carl Icahn, who recently took a big stake in the company. The post ... | |
| Bausch Health Adds Two Icahn Group Membe... | 02/24/21 |
| Bausch Health added two directors from Icahn Group. The New York investor Carl Icahn this month disclosed a 7.8% stake in the medical-device maker. | |
| Bausch Health Companies reports fourth-q... | 02/24/21 |
| LAVAL, Que. ??? Bausch Health Companies Inc. reported a loss of US$153 million in its latest quarter as its revenue edged lower compared with a year a... | |
| The Daily Biotech Pulse: Bausch Calls Tr... | 02/24/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 23) Axo... | |
| Bausch Health Companies Inc. Announces F... | 02/24/21 |
| LAVAL, Quebec, Feb. 24, 2021 /PRNewswire/ -- Fourth-Quarter 2020 Financial Results Revenues of $2.213 Billion GAAP Cash Generated from Operations of $... | |
| Cosmetic Surgery Market to see Huge Grow... | 02/24/21 |
| Stay up-to-date and exploit latest trends of Cosmetic Surgery Market with latest edition released by AMA. Cosmetic Surgery Market Comprehensive Study ... | |
| Earnings Scheduled For February 24, 2021 | 02/24/21 |
| Companies Reporting Before The Bell ??? Pinnacle West Capital (NYSE: PNW ) is expected to report quarterly earnings at $0.04 per share on revenue of $... | |
| Bausch + Lomb Launches Alaway?? Preserva... | 02/23/21 |
| First FDA-Approved OTC Preservative-Free Antihistamine Eye Drop Approved for Relief of Itchy Eyes Associated with Allergies Now Rolling out to Major U... | |
| Bausch Health Companies Earnings Report:... | 02/23/21 |
| Bausch Health Companies announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by?... | |
| Bausch Health To Reduce Debt By $100 Mil... | 02/22/21 |
| LAVAL, QC, Feb. 22, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduc... | |
| The $1M IPO bonus, decent pay and a nice... | 02/22/21 |
| Mark McKenna raised a few eyebrows when he jumped from the CEO spot at Bausch sub Salix to take charge of a low-profile biotech startup called Prometh... | |
| Global Eye Health Supplements Market Tra... | 02/18/21 |
| DUBLIN--(BUSINESS WIRE)--The "Eye Health Supplements - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offerin... | |
| Salix Announces 2021 Gastrointestinal He... | 02/18/21 |
| LAVAL, QC, Feb. 18, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology (GI) business, Salix ... | |
| The Daily Biotech Pulse: Lily-Rigel Lice... | 02/18/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17) Adv... | |
| Global Uveitis treatment Market (2020 to... | 02/18/21 |
| DUBLIN--(BUSINESS WIRE)--The "Global Uveitis treatment Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global uveiti... | |
| Top Analyst Upgrades and Downgrades: Agi... | 02/17/21 |
| No summary available. | |
| $1,000, 5 Years Later: Valeant's Wild Ri... | 02/16/21 |
| Investors who have owned stocks since 2016 generally have experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY ) total return in the last ... | |
| Billionaire Carl Icahn Eyes Board Member... | 02/12/21 |
|
Billionaire Carl Icahn said he intended to negotiate ways to improve shareholder value with its board and executives, particularly in the current s... |
|
| Carl Icahn Discloses a Stake in Bausch H... | 02/12/21 |
| Bausch Health stock got an added boost Friday after billionaire investor Carl Icahn disclosed a 7.8% stake in the pharmaceutical and medical device co... | |
| Bausch Health Jumps on Carl Icahn Invest... | 02/12/21 |
| Carl Icahn acquired 27.8 million shares of Bausch in a purchase that makes him the company's largest single shareholder. | |
| The Daily Biotech Pulse: European Regula... | 02/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D ... | |
| Bausch Health rallies toward 10th straig... | 02/12/21 |
| Shares of Bausch Health Companies Inc. undefined rallied 5.8% in premarket trading Friday, putting them on track for a 10th straight gain, after billi... | |
| Bausch Health Responds To Schedule 13D F... | 02/11/21 |
| LAVAL, QC, Feb. 11, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") issued the following statemen... | |
| Impact of Covid-19 On Dermatology Treatm... | 02/11/21 |
| The "Global Dermatology Treatment Devices Market Analysis to 2027" is a specialized and in-depth study of the Dermatology Treatment Devices market wit... | |
| The Daily Biotech Pulse: Lilly COVID-19 ... | 02/10/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 M... | |
| Hold rating | 02/26/21 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $22.00 to $35.00 | |
| Strong Buy rating | 02/17/21 |
| RBC Capital upgrades from Sector Perform to Outperform rating and raises Price Target from $26.00 to $42.00 | |
| Date | 2021-02-24 (BMO) | Est. (EPS/Rev.) | $1.12/ 2.17B |
| Actual (EPS/Rev.) | $1.33/ $2.21 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swingtrades | R. belegger | 83.00 % | Follow |
| Analyst Rating Investments | BigMoveTrader | 69.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.